Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

MLA

Dawed, Adem Y., et al. “Pharmacogenomics of GLP-1 Receptor Agonists: A Genome-Wide Analysis of Observational Data and Large Randomised Controlled Trials.” The Lancet Diabetes & Endocrinology, vol. 11, no. 1, Jan. 2023, pp. 33–41. EBSCOhost, https://doi.org/10.1016/S2213-8587(22)00340-0.

APA

Dawed, A. Y., Mari, A., Brown, A., McDonald, T. J., Li, L., Wang, S., Hong, M.-G., Sharma, S., Robertson, N. R., Mahajan, A., Wang, X., Walker, M., Gough, S., Hart, L. M. ‘t, Zhou, K., Forgie, I., Ruetten, H., Pavo, I., Bhatnagar, P., … Wu, H. (2023). Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials. The Lancet Diabetes & Endocrinology, 11(1), 33–41. https://doi.org/10.1016/S2213-8587(22)00340-0

Chicago

Dawed, Adem Y, Andrea Mari, Andrew Brown, Timothy J McDonald, Lin Li, Shuaicheng Wang, Mun-Gwan Hong, et al. 2023. “Pharmacogenomics of GLP-1 Receptor Agonists: A Genome-Wide Analysis of Observational Data and Large Randomised Controlled Trials.” The Lancet Diabetes & Endocrinology 11 (1): 33–41. doi:10.1016/S2213-8587(22)00340-0.